Shigella species susceptibility to commonly used antimicrobials in the Temuco Regional Hospital, Chile 1990-2001;Comparación de susceptibilidad de especies de Shigella a antimicrobianos de uso habitual en el Hospital Regional de Temuco, Chile 1990-2001

Revista Medica de Chile

Volumn 130, Issue 9, 2002, Pages 1021-1026

  Boehme K, Cecilia ^a,b   Iglesias S, Trinidad ^a   Loyola M, Aurora ^a   Soto F, Lilian ^a   Rodríguez M, Gloria ^a   Reydet B, Patricia ^a   Illesca B, Vijna ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b NONE   (Chile)

Author keywords

Antibiotics; Microbial sensitivity tests; Shigella

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CHILE; COMPARATIVE STUDY; DRUG EFFECT; FECES; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; SHIGELLA;

CHILD; CHILE; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FECES; HUMANS; MICROBIAL SENSITIVITY TESTS; SHIGELLA;

EID: 0036728297     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. KEUSCH G, BENNISH M. Shigellosis. Recent progress, persisting problems and research issues. Pediatr Infect Dis J 1989; 8: 713-9.
2. HALPERN Z, DAN M, GILADI M, SCHWARTZ I, SELA O, LEVO Y. Shigellosis in adults: Epidemiologic, clinical and laboratory features. Medicine 1989; 68: 210-7.
3. GREEN M, BLOCK C, COHEN D, SLATER P. Four decades of shigellosis in Israel: epidemiology of a growing public health problem. Rev Infect Dis 1991; 13: 248-53.
4. VARSANO I, EIDLITZ-MARCUS T, NUSSINOVITCH M, ELIAN I. Comparative efficacy of Cerftriaxone and Ampicillin for treatment of severe shigellosis in children. J Pediatr 1991; 118: 627-32.
5. PICKERING L, DU PONT H, OLARTE J. Single dose tetracycline therapy for shigellosis in adults. JAMA 1978; 239: 853-4.
6. CHANG M, DUNKLE L, VAN REKEN D, ANDERSON D, WONG M, FEIGIN R. Trimethoprim-Sulfametoxazole compared to Ampicillin in the treatment of shigellosis. Pediatrics 1977; 59: 726-9.
7. SALAM M, BENNISH M. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis. J Pediatr 1988; 113: 901-7.
8. PRADO V, BANFI A, DONOSO E. Evaluación clínico-bacteriológica del uso de cotrimoxazol en shigellosis. Rev Chil Pediatr 1915; 46: 25-9.
9. D'OTTONE K, ASTORGA J, ZAPATA L, SEOANE M. Susceptibilidad antimicrobiana de 561 cepas de Shigella obtenidas de muestras clinicas. Rev Chil Infect 1985; 2: 57-60.
10. SOLÓRZANO F, LEAÑOS B, GUISCAFRÉ H. Resistencia antimicrobiana actual de Salmonella typhy, Salmonella enteritidis y Shigella sp. Bol Med Hosp Infant Mex 1987; 44: 448-55.
11. FROST J, ROWE B, VANDEPITTE J, THRELFALL E. Plasmid characterization in the investigation of an epidemic caused by multiply resistant Shigella dysenteriœ type 1 in Central Africa. Lancet 1981; II: 1074-6.
12. MUNSHI M, HAIDER K, RAHAMAN M, SACK D, AHMED Z, MORSHED M. Plasmid mediated resistance to nalidixic acid in Shigella dysenteriœ Type 1. Lancet 1987; II: 419-21.
13. BENNISH M, EUSOF A, KAY B. Multiresistant Shigella infections in Bangladesh. Lancet 1985; II: 441.
14. URBINA R, PRADO V, CANELO E. Trimethoprim resistance in enterobacteria isolated in Chile. J Antimicrob Chemother 1989; 23: 143-9.
15. GRIFFIN P, TAUXE R, REDD S, PUHR N, HARGRETT-BEAN N, BLAKE P. Emergence of highly Trimethoprim-Sulfamethoxazole-Resistant Shigella in a native American population: an epidemiologic study. Am J Epidemiol 1989; 129: 1042-51.
16. SIRI M, SANTOLAYA M, CÓRDOVA M, TORRES T. Sensibilidad in vitro de Shigella y correlación clínica después de la administración de cotrimoxazol oral. Rev Chil Infect 1989; 6: 106-8.
17. PRADO V, REYES L, URBINA M, PHILLIPS M. Resistencia de bacterias enteropatógenas a antimicrobianos de uso habitual. Rev Chil Pediatr 1984; 55: 308-12.
18. LIMA A, LIMA L, PINHO M, BARROS E, TEIXEIRA M, MARTINS M ET AL. High frequency of strains multiply resistant to Ampicillin, Trimethoprim-Sulfamethoxazole, Streptomycin, Cloramphenicol and Tetracycline isolated from patients with shigellosis in Northeastern Brazil during the period 1988 to 1993. Antimicrob Agents Chemother 1995; 39; 256-9.
19. VILA J, GASCON J, ABDALLA S, GÓMEZ J, MARCO F, MORENO A ET AL. Antimicrobial resistance of Shigella isolated causing traveler's diarrhea. Antimicrob Agents Chemother 1994; 38: 2668-70.
20. BENNISH M, SALAM M, HOSSAIN M, MYAUX J, KHAN E, CHAKRABORTY J ET AL. Antimicrobial resistance of Shigella isolated in Bangladesh, 1983-1990: Increasing frecuency of strains multiply resistant to Ampicillin, Trimethoprim-Sulfamethoxazole and Nalidixic Acid. Clin Infect Dis 1992; 14: 1055-60.
21. SACK R, RAHMAN M, YUNUS M, KHAN E. Antimicrobial resistance in organisms causing diarrheal disease. Clin Infect Dis 1997; 24 Suppl 1: 102-5.
22. PRADO V, PIDAL P, ARELLANO C, LAGOS R, SAN MARTIN O, LEVINE M. Multirresistencia antimicrobiana en cepas de Shigella sp en una comuna semi rural del área norte de Santiago. Rev Méd Chile 1998; 1464-71.
23. BOEHME C, RODRÍGUEZ G, ILLESCA V, REYDET P, SERRA J. Shigellosis infantil en la IX Región: aspectos clínicos, epidemiológicos y estudio de sensibilidad. Rev Méd Chile 1992; 120: 1261-6.
24. KELLY M, BRENNER D, FARMER J. Enterobacteriaceœ. En: Lennette E, Balows A, Hausler W, Shadomy J eds. Manual de Microbiología Clínica, Buenos Aires: Editorial Médica Panamericana 1987; 336-52.
25. KONEMAN E, ALLEN S, JANDA W, SCHRECKENBERGER P, WINN W. Pruebas de sensibilidad a agentes antimicrobianos. En: Diagnóstico microbiológico. Buenos Aires: Editorial Panamericana 1999; 805-7.
26. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS 1998. Performance standards for antimicrobial susceptibility testing. Eight informational supplement.
27. OLIVA P, MUÑOZ F, ARAVENA P, BALBOA W, MAMANI J, MUÑOZ G. Shigellosis infantil en la IX Región. Rev Chil Pediatr 1988; 59: 275-8.
28. PRADO V, LAGOS R, NATARO J, SAN MARTIN O, ARELLANO C, WANG J ET AL. Population based study of the incidence of Shigella diarrhea and causative serotypes in Santiago, Chile. Pediatr Infect Dis J 1999; 18: 500-5.
29. FERRECCIO C, PRADO V, OJEDA A, CAYYAZO M, ABREGO P, GUERS L ET AL. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. Am J Epidemiol 1991; 134: 614-27.
30. PRADO V, O'RYAN M. Acute gastroenteritis in Latin America. Infect Dis Clin North Am 1994; 8: 77-106.
31. PIDAL P, PRADO V, TRUCCO O, VALDIVIESO F, DIAZ M, OJEDA A, GRUPO PRONARES. Rev Panam Infectol 1999; 1: S18-S25.
32. DELPIANO L, TEJERINA H, CONA E, AVILES C. Patrones de sensibilidad in vitro y comportamiento clinico de Shigella. Rev Chil Infect 2001; 18: 101-7.
33. FONTAINE O. Antibiotics in the management of shigellosis in children: what role for the quinolones. Rev Infect Dis 1989; 11 Suppl 5: 1145-50.
34. KHAN W, SEAS C, DHAR U, SALAM M, BENNISH M. Treatment of shigellosis: V. Comparison of Azithromycin and Ciprofloxacin. A Double-Blind, Randomized, Controlled, Trial. Ann Intern Med 1997; 126: 697-703.
35. GREEN S, TILLOTSON G. Use of Ciprofloxacin in developing countries. Pediatr Infect Dis J 1997; 16: 150-9.
36. SCHAAD U, SALAM M, AUJARD Y, DAGAN R, GREEN S, PELTOLA H ET AL. Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy Commision. Pediatr Infect Dis J 1995; 14: 1-9.
37. SALAM M, DHAR U, KHAN W, BENNISH M. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis. Lancet 1998; 352: 522-7.
38. GROSSMAN E, WALCHECK A, FREEDMAN H. Tetracycline and permanent teeth: the relationship betwen doses and tooth color. Pediatrics 1971; 47: 567-70.
39. ASHKENAZI S, MAY-ZAHAV M, SULKES J, ZILBELBERG R, SAMRA Z. Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992. Antimicrob Agent Chemother 1995; 39: 819-23.
40. MURRAY B. Resistance of Shigella, Salmonella and other selected enteric pathogens to antimicrobial agents. Rev Infect Dis 1986; 8 Suppl 2: 172-80.